Study protocol in children on the autism spectrum

Published On: 24 Sep, 2022 12:35 PM | Updated On: 19 May, 2024 10:45 PM

Study protocol in children on the autism spectrum

Longitudinal trajectory methods, featuring outcome assessments at three or more time points, are used as appropriate approaches for understanding the developmental pathways of people on the autism spectrum across the lifespan. Apprehending the scope of this rapidly expanding body of research can help advise future trajectory studies and identify areas for potential meta-analysis as well as crucial evidence gaps.

A recent study protocol states that it aims to identify and summarise the scope of research that uses a longitudinal trajectory study design to examine development in children diagnosed with autism. It will specifically identify well-characterized outcome domains and age intervals, areas of further research, and the historical use of various longitudinal trajectory analytical approaches.

The study will outline the methods for the proposed scoping review according to the framework outlined by Arksey and O'Malley, with subsequent clarifications and enhancements by other authors. The study will explore six databases for relevant publications, using a search strategy developed by a medical librarian. It will screen Titles and abstracts for duplicates, followed by full-text screening. It will also chart relevant data using data extraction fields developed predominantly a priori from a set of guiding subquestions. The findings will include quantitative aggregate summaries, narrative summaries, and appraisal of trajectory studies according to the set methodological subquestions. Further, autistic self-advocate and parent-caregiver stakeholders will help facilitate the interpretation of the findings.

This review will not require Research ethics approval. Its results will be available for the researchers, care professionals, policy-makers, and stakeholder audiences at local and international conferences and other dissemination activities and will be published in a peer-reviewed journal.

Source: BMJ Open. 2021 Nov 22;11(11):e053443. doi: 10.1136/bmjopen-2021-053443. PMID: 34810191; PMCID: PMC8609941.

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks